Drug company introduces generic insulin at half the price of brand-name drug

Pharmaceutical company Eli Lilly will sell a cheaper generic version of its rapid-acting insulin Humalog, according to a statement Monday from Chairman and CEO Dave Ricks.

Click Here to read the entire article...